DK1939204T3 - Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf - Google Patents
Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse derafInfo
- Publication number
- DK1939204T3 DK1939204T3 DK06811925.4T DK06811925T DK1939204T3 DK 1939204 T3 DK1939204 T3 DK 1939204T3 DK 06811925 T DK06811925 T DK 06811925T DK 1939204 T3 DK1939204 T3 DK 1939204T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- same
- composition containing
- medical use
- condensed heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005304395 | 2005-10-19 | ||
| JP2006147019 | 2006-05-26 | ||
| PCT/JP2006/320681 WO2007046392A1 (ja) | 2005-10-19 | 2006-10-17 | 縮合複素環誘導体、それを含有する医薬組成物及びその医薬用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK1939204T3 true DK1939204T3 (da) | 2013-03-11 |
| DK1939204T6 DK1939204T6 (da) | 2022-09-05 |
Family
ID=37962485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06811925.4T DK1939204T6 (da) | 2005-10-19 | 2006-10-17 | Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9040693B2 (da) |
| EP (1) | EP1939204B3 (da) |
| JP (2) | JP4955566B2 (da) |
| KR (1) | KR101384132B1 (da) |
| AU (1) | AU2006305271B2 (da) |
| BR (1) | BRPI0617436B8 (da) |
| CA (1) | CA2624492C (da) |
| CY (1) | CY1113898T1 (da) |
| DK (1) | DK1939204T6 (da) |
| ES (1) | ES2398917T7 (da) |
| HK (1) | HK1125110A1 (da) |
| IL (1) | IL190754A (da) |
| NL (1) | NL301202I2 (da) |
| NO (1) | NO343185B1 (da) |
| NZ (1) | NZ567300A (da) |
| PL (1) | PL1939204T6 (da) |
| PT (1) | PT1939204E (da) |
| RU (1) | RU2418803C2 (da) |
| SI (1) | SI1939204T1 (da) |
| TW (1) | TWI400074B (da) |
| WO (1) | WO2007046392A1 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8263588B2 (en) * | 2007-04-06 | 2012-09-11 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| CN101678007B (zh) | 2007-04-06 | 2013-07-03 | 纽罗克里生物科学有限公司 | 促性腺激素释放激素受体拮抗剂及其制药用途 |
| CA2682400A1 (en) * | 2007-04-18 | 2008-11-06 | Kissei Pharmaceutical Co., Ltd. | Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| EP2147922B1 (en) | 2007-04-18 | 2017-08-02 | Kissei Pharmaceutical Co., Ltd. | Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| KR101631143B1 (ko) | 2010-02-10 | 2016-06-17 | 깃세이 야쿠힌 고교 가부시키가이샤 | 축합 복소환 유도체의 염 및 그 결정 |
| WO2014030743A1 (ja) | 2012-08-24 | 2014-02-27 | 武田薬品工業株式会社 | 複素環化合物 |
| JP6268093B2 (ja) * | 2012-09-14 | 2018-01-24 | キッセイ薬品工業株式会社 | 縮合複素環誘導体の製造方法およびその製造中間体 |
| JP6574444B2 (ja) * | 2014-01-06 | 2019-09-11 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 炭素環式スルホンＲＯＲγ調節因子 |
| AU2017309015B2 (en) * | 2016-08-08 | 2022-09-15 | Kissei Pharmaceutical Co., Ltd. | Administration and dosage of therapeutic agent for endometriosis |
| WO2018144603A1 (en) * | 2017-01-31 | 2018-08-09 | Veru Inc. | COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GANADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS |
| EP3634419A1 (en) | 2017-06-05 | 2020-04-15 | ObsEva S.A. | Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss |
| CA3066190A1 (en) | 2017-06-05 | 2018-12-13 | ObsEva S.A. | Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis |
| EP4086245A1 (en) * | 2018-01-30 | 2022-11-09 | Incyte Corporation | Processes for preparing intermediates for the synthesis of a jak inhibitor |
| US20220117969A1 (en) | 2018-10-29 | 2022-04-21 | ObsEva S.A. | Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis |
| US20230067378A1 (en) | 2018-11-07 | 2023-03-02 | ObsEva S.A. | Compositions and methods for the treatment of estrogen-dependent disorders |
| KR20220045198A (ko) * | 2019-08-08 | 2022-04-12 | 옵스에파 에스에이 | 에스트로겐-의존성 장애의 치료를 위한 gnrh 길항제 |
| KR20220061120A (ko) | 2019-08-08 | 2022-05-12 | 옵스에파 에스에이 | 에스트로겐-의존성 장애 치료용 조성물 및 방법 |
| WO2022179469A1 (zh) * | 2021-02-23 | 2022-09-01 | 南京明德新药研发有限公司 | 噻吩并嘧啶二酮类化合物及其应用 |
| JP2024507408A (ja) * | 2021-02-23 | 2024-02-19 | ソーター・バイオファーマ・プライベイト・リミテッド | 縮合多環式置換５－カルボン酸チエノピリミジンジオン化合物およびその使用 |
| WO2024037532A1 (zh) * | 2022-08-16 | 2024-02-22 | 深圳市康哲生物科技有限公司 | 一种噻吩并嘧啶酮衍生物的盐型及晶型 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0781774B1 (en) | 1995-12-08 | 2002-07-31 | Takeda Chemical Industries, Ltd. | Prolactin production inhibitory agents |
| WO1997040846A1 (en) | 1996-04-30 | 1997-11-06 | Takeda Chemical Industries, Ltd. | COMBINED USE OF GnRH AGONIST AND ANTAGONIST |
| WO1997044339A1 (en) | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| GB0124627D0 (en) | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
| EP1687306A1 (en) * | 2003-11-14 | 2006-08-09 | MERCK SHARP & DOHME LTD. | Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| JP2007514757A (ja) | 2003-12-19 | 2007-06-07 | メルク エンド カムパニー インコーポレーテッド | 有糸分裂キネシン阻害剤 |
| JPWO2006083005A1 (ja) | 2005-02-03 | 2008-06-26 | 武田薬品工業株式会社 | 縮合ピリミジン誘導体およびその用途 |
-
2006
- 2006-10-17 ES ES06811925T patent/ES2398917T7/es active Active
- 2006-10-17 RU RU2008119462/04A patent/RU2418803C2/ru active
- 2006-10-17 DK DK06811925.4T patent/DK1939204T6/da active
- 2006-10-17 WO PCT/JP2006/320681 patent/WO2007046392A1/ja active Application Filing
- 2006-10-17 JP JP2007540993A patent/JP4955566B2/ja active Active
- 2006-10-17 SI SI200631557T patent/SI1939204T1/sl unknown
- 2006-10-17 KR KR1020087010997A patent/KR101384132B1/ko active IP Right Grant
- 2006-10-17 PL PL06811925.4T patent/PL1939204T6/pl unknown
- 2006-10-17 NZ NZ567300A patent/NZ567300A/en unknown
- 2006-10-17 AU AU2006305271A patent/AU2006305271B2/en active Active
- 2006-10-17 BR BRPI0617436A patent/BRPI0617436B8/pt active IP Right Grant
- 2006-10-17 EP EP06811925.4A patent/EP1939204B3/en active Active
- 2006-10-17 PT PT68119254T patent/PT1939204E/pt unknown
- 2006-10-17 CA CA2624492A patent/CA2624492C/en active Active
- 2006-10-17 US US12/089,674 patent/US9040693B2/en active Active
- 2006-10-19 TW TW095138520A patent/TWI400074B/zh active
-
2008
- 2008-04-09 IL IL190754A patent/IL190754A/en active IP Right Grant
- 2008-05-19 NO NO20082249A patent/NO343185B1/no unknown
-
2009
- 2009-04-09 HK HK09103380.3A patent/HK1125110A1/xx unknown
-
2012
- 2012-01-19 JP JP2012008680A patent/JP5319797B2/ja active Active
-
2013
- 2013-04-02 CY CY20131100276T patent/CY1113898T1/el unknown
-
2022
- 2022-11-01 NL NL301202C patent/NL301202I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1939204T3 (da) | Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf | |
| NO20081604L (no) | Nitrogeninneholdende heterocyklisk forbindelse og farmasøytisk anvendelse derav | |
| IL192184A0 (en) | Heterocyclic derivatives and pharmaceutical compositions containing the same | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| HK1099556A1 (en) | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | |
| EP1876178A4 (en) | CYANOPYRIDINE DERIVATIVE AND THE USE THEREOF AS A MEDICAMENT | |
| NO345062B1 (no) | 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy) pyrimidinbaserte forbindelser og anvendelse derav | |
| DK1928879T3 (da) | Kondenserede heterocykliske forbindelser og anvendelse heraf som kinase-modulatorer | |
| BRPI0810523A2 (pt) | Derivado heterocíclico de 5 membros e uso do mesmo para propósitos médicos. | |
| IL192298A (en) | Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them | |
| DK2207773T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning deraf. | |
| RU2398586C3 (ru) | Фармацевтическая композиция | |
| IL191141A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL186665A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL187434A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| DK1894567T3 (da) | Ledsagende farmaceutiske midler og anvendelse deraf | |
| DK1962873T3 (da) | Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier | |
| EP2157093A4 (en) | HETEROCYCLIC PYRROLO-NITROGEN-DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE | |
| DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
| DK2234968T3 (da) | (aza)indolderivat substitueret i position 5, farmaceutisk sammensætning omfattende det, mellemliggende forbindelser og fremstillingsproces dertil | |
| ATE420081T1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
| BRPI0819202A2 (pt) | Derivado heterocíclico, e, composição farmacêutica | |
| DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1940840T3 (da) | 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf | |
| BRPI0614413A2 (pt) | composto, e, composição farmacêutica |